We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cancer Related Fatigue in Patients Receiving Chemotherapy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2006 by Medical Center Alkmaar.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00261534
First Posted: December 5, 2005
Last Update Posted: September 14, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Medical Center Alkmaar
  Purpose
The purpose of this study is to examine the degree of fatigue in patients receiving chemotherapy. Special interest goes out to the course of fatigue throughout five treatments and the actions taken by patients to reduce this fatigue.The correlation between fatigue and haemoglobin will also be subject of study.

Condition
Cancer Fatigue

Study Type: Observational
Study Design: Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Outcomes Research on the Course of Cancer Related Fatigue Throughout Five Chemotherapy Treatments

Resource links provided by NLM:


Further study details as provided by Medical Center Alkmaar:

Estimated Enrollment: 90
Study Start Date: January 2006
Estimated Study Completion Date: July 2006
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of cancer requiring chemotherapy treatment

Exclusion Criteria:

  • Pregnancy
  • Psychological illness
  • Life expectancy less than three months
  • Lack of basic proficiency in Dutch
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00261534


Locations
Netherlands
Medical Centre Alkmaar
Alkmaar, Noord-Holland, Netherlands, 1815JD
Sponsors and Collaborators
Medical Center Alkmaar
Investigators
Study Director: D. Hilarius, MSc Medical Centre Alkmaar, Hospital Pharmacy
  More Information

ClinicalTrials.gov Identifier: NCT00261534     History of Changes
Other Study ID Numbers: M05-057
First Submitted: December 1, 2005
First Posted: December 5, 2005
Last Update Posted: September 14, 2006
Last Verified: September 2006

Keywords provided by Medical Center Alkmaar:
Chemotherapy

Additional relevant MeSH terms:
Fatigue
Signs and Symptoms